To confirm that IL-6 enhancement of ovarian cancer cell migration depends on glucose metabolism, we performed a wound healing scratch assay in the presence of 2-deoxy-D-glucose (2-DG) or sodium oxamate, which inhibit upstream and downstream the glycolytic pathway, respectively. The gene discussed is IL6; the disease is ovarian cancer.